What is Sotrovimab?

Sotrovimab, also known as Xevudy, is a medicine used to treat COVID-19. It is a monoclonal antibody, which means it is a special protein designed to help the body fight the virus. It is used for people at high risk of severe illness from COVID-19, such as older adults or those with health problems.

How Does Sotrovimab Work?

Sotrovimab attaches to the COVID-19 virus and stops it from spreading in the body. This helps reduce symptoms and lowers the chance of severe illness or hospitalization. It is not a vaccine but a treatment for people who are already infect.

Who Can Take Sotrovimab?

Doctors may give Sotrovimab to:

• People with mild or moderate COVID-19 who are at risk of getting very sick.
• Older adults and people with diabetes, heart disease, lung disease, or weak immune systems.
• Patients who cannot take other COVID-19 treatments.

How is Sotrovimab Give?

• It is give as a one-time intravenous (IV) infusion in a hospital or clinic.
• The infusion takes about 30 minutes.
• After the infusion, the patient is monitored for an hour to check for side effects.

Benefits of Sotrovimab

• Reduces the risk of severe COVID-19 and hospitalization.
• Works against different COVID-19 variants.
• Provides protection for high-risk patients.

Possible Side Effects

Like all medicines, Sotrovimab may cause some side effects. These include:

Common Side Effects

• Feeling tired or weak
• Fever or chills
• Nausea
• Headache

Serious Side Effects (Rare but Dangerous)

• Allergic reaction (swelling of face, lips, or throat)
• Shortness of breath or chest pain
• Severe dizziness or fainting

If you experience serious side effects, seek medical help immediately.

Who Should Not Take Sotrovimab?

Sotrovimab may not be safe for:

• People allergic to monoclonal antibodies.
• Patients with severe COVID-19 requiring oxygen (it may not be as effective in late stages).
• Pregnant or breastfeeding women (consult a doctor first).

Warnings and Precautions

• Sotrovimab is not a substitute for a COVID-19 vaccine.
• It should be take early in the infection for best results.
• Inform your doctor about any allergies or health conditions before taking it.

Conclusion

Sotrovimab (Xevudy) is a helpful treatment for high-risk COVID-19 patients. It reduces the risk of severe illness and hospitalization when given early. However, it should only be use under medical supervision. If you have concerns, talk to a healthcare professional before receiving Sotrovimab.